Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Follows Its Own Business Development Model into Molecular Diagnostics

May 01 2010

Related Content

Will COX-2 + Biomarker = Success? Novartis Tests the Frontiers of Companion Diagnostics

Mar 03 2010

Does Roche Have It Right?

Jul 01 2007

Novartis's Research Experiment

May 01 2006

Novartis Reorganizes Its US Pharma Unit, Replacing CEO And Slashing 250 Jobs

Apr 14 2010

GSK's Early Link-Up with Abbott for an Immunotherapy Companion Diagnostic

Jul 01 2009

Newly Discovered Polymorphism May Have Immediate Impact in HCV

Sep 01 2009

Related Companies

Novartis AG

Novartis AG

Novartis AG

Roche Holding AG

Abbott

Ventana Medical Systems, Inc.

GSK plc

Pfizer Inc.

Merck & Co., Inc.

Agendia

Merck & Co., Inc.

Laboratory Corporation of America

Orion Genomics LLC

Transgene S.A.

bioMerieux SA

Additional Topics

Strategy Business Strategies Platform Technologies Medical Device

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window